STC-3141

N/A

Report date: 2023/10/13 20:08:36
NME

Base Information

Drug NameSTC-3141
Drug Alias NameSTC-3141STC314STC-314
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone modulatorsneutrophil-derived extracellular traps modulators
TargetsHistone
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Respiratory Distress Syndrome, AdultSepsis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesChina Grand Pharmaceutical And Healthcare Holdings Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSypharma Pty LtdGrand Medical Pty LtdGrand Pharmaceutical （China） Co Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Respiratory Distress Syndrome, AdultSepsis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A